1. Home
  2. Analysis
  3. Fingolimod
  4. Hepatitis-e

Fingolimod and Hepatitis e - a phase IV clinical study of FDA data

Summary:

Hepatitis e is reported as a side effect among people who take Fingolimod (fingolimod), especially for people who are female, 20-29 old, have been taking the drug for 10+ years also take Cellcept, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Hepatitis e when taking Fingolimod. It is created by eHealthMe based on reports of 5,142 people who have side effects when taking Fingolimod from the FDA, and is updated regularly.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 5,150 Fingolimod users. Check the latest studies of Fingolimod.

What is Hepatitis e?

Hepatitis e is found to be associated with 117 drugs and 182 conditions by eHealthMe. Check the latest studies of Hepatitis e.

On Jul, 30, 2026

5,142 people reported to have side effects when taking Fingolimod.
Among them, 12 people (0.23%) have Hepatitis e.

Could Fingolimod cause Hepatitis e?

Among these 12 people:

How long have people been on Fingolimod when they have Hepatitis e? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 100 %

What is the gender of people who have Hepatitis e when taking Fingolimod? *

  • female: 58.33 %
  • male: 41.67 %

What is the age of people who have Hepatitis e when taking Fingolimod? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 40 %
  • 30-39: 20 %
  • 40-49: 30 %
  • 50-59: 10 %
  • 60+: 0.0 %

What are other drugs people take besides Fingolimod? *

  1. Oxybutynin: 1 person, 8.33%
  2. Neoral: 1 person, 8.33%
  3. Medrol: 1 person, 8.33%
  4. Glatiramer Acetate: 1 person, 8.33%
  5. Ciclosporin: 1 person, 8.33%
  6. Cellcept: 1 person, 8.33%

What are other side effects people have besides Hepatitis e? *

  1. Hepatic Enzyme Increased: 3 people, 25.00%
  2. Diarrhea Haemorrhagic: 2 people, 16.67%
  3. Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 8.33%
  4. Pneumomediastinum (air is present in the mediastinum): 1 person, 8.33%
  5. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 1 person, 8.33%
  6. Herpes Zoster: 1 person, 8.33%
  7. Fatigue (feeling of tiredness): 1 person, 8.33%

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 50.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
  3. Immunodeficiency Disorders: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fingolimod and have Hepatitis e?

- Check whether Hepatitis e is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fingolimod:

Hepatitis e treatments and more:

How severe was Hepatitis e and when was it recovered:

Expand to all the drugs that have ingredients of fingolimod:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fingolimod:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis e:

Browse all the conditions that are associated with Hepatitis e:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod (the active ingredients of Fingolimod) and Fingolimod (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.